Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XFOR

X4 Pharmaceuticals Inc

May 01 • 01:58PM ET

4.14

+0.07 1.72 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BMRN RGNX SRRK KRYS PRTA MCRB ADAP CLLS ADVM ONCT

| Held by: VTI VXF PRFZ AVSC BTEC URTY ITWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.34	Insider Own	22.16%	Shs Outstand	90.91M	Perf Week	0.73%
Market Cap	376.40M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	0.00%	Shs Float	70.77M	Perf Month	-4.83%
Enterprise Value	199.88M	PEG	-	EPS next Q	-0.20	Inst Own	80.25%	Short Float	4.44%	Perf Quarter	11.89%
Income	-79.20M	P/S	10.72	EPS this Y	53.30%	Inst Trans	56.80%	Short Ratio	6.30	Perf Half Y	10.70%
Sales	35.11M	P/B	2.02	EPS next Y	5.34%	ROA	-36.25%	Short Interest	3.14M	Perf YTD	3.50%
Book/sh	2.05	P/C	1.48	EPS next 5Y	27.93%	ROE	-75.99%	52W High	4.83 -14.29%	Perf Year	10.40%
Cash/sh	2.79	P/FCF	-	EPS past 3/5Y	65.48% 54.19%	ROIC	-30.16%	52W Low	1.35 206.67%	Perf 3Y	-91.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 63.56%	Gross Margin	82.17%	Volatility	5.66% 6.02%	Perf 5Y	-98.35%
Dividend TTM	-	EV/Sales	5.69	EPS Y/Y TTM	21.69%	Oper. Margin	-247.44%	ATR (14)	0.26	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.97	Sales Y/Y TTM	1273.21%	Profit Margin	-225.55%	RSI (14)	50.75	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.15	EPS Q/Q	96.32%	SMA20	-0.14%	Beta	0.32	Target Price	11.67
Payout	-	Debt/Eq	0.41	Sales Q/Q	79.08%	SMA50	4.29%	Rel Volume	0.34	Prev Close	4.07
Employees	45	LT Debt/Eq	0.41	Earnings	Mar 17 BMO	SMA200	18.40%	Avg Volume	498.78K	Price	4.14
IPO	Nov 16, 2017	Option/Short	No / Yes	EPS/Sales Surpr.	19.27% 48.18%	Trades		Volume	118,283	Change	1.72%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)